Nedocromil sodium in adults with asthma dependent on inhaled corticosteroids: a double blind, placebo controlled study

Bone, M F; Kubik, M M; Keaney, N P; Summers, G D; Connolly, C K; Burge, P S; Dent, R G; Allan, G W
August 1989
Thorax;Aug1989, Vol. 44 Issue 8, p654
Academic Journal
No abstract available.


Related Articles

  • This asthma treatment has a lasting side effect in children. Nissly, Tanner; Prasad, Shailendra; Stevermer, James // Journal of Family Practice;Sep2013, Vol. 62 Issue 9, p500 

    The article offers information on the Childhood Asthma Management Program (CAMP) which studies the side effects of inhaled corticosteroids (ICS) for the treatment of asthma in children. A double-blind, placebo-controlled randomized controlled trial (RCT) was conducted to study the linear growth...

  • Is budesonide or nedocromil superior in the long-term management of mild to moderate asthma in children? Stella, Meri Feaver; Newton, Warren // Journal of Family Practice;Jan2001, Vol. 50 Issue 1, p70 

    The article discusses research being done on the long-term effects of budesonide or nedocromil in children with asthma, with reference to a study by the Childhood Asthma Management Program Research Group, which was published in the 2000 issue of the "New England Journal of Medicine." The...

  • How effective are leukotriene inhibitors for asthma in children? Morden, Nancy E.; St. Anna, Leilani // Journal of Family Practice;Apr2004, Vol. 53 Issue 4, p325 

    explains that leukotrienes are potent mediators of inflammation and are believed to contribute significantly to the inflammatory pathophysiology of asthma. Leukotriene inhibitors interfere with leukotriene production or leukotriene receptors and thus inhibit inflammation. For children, the...

  • Budesonide Inhalation Suspension: A Review of its Use in Infants, Children and Adults with Inflammatory Respiratory Disorders. Hvizdos, K.M.; Jarvis, B. // Drugs;Nov2000, Vol. 60 Issue 5, p1141 

    Budesonide, a topically active corticosteroid, has a broad spectrum of clinically significant local anti-inflammatory effects in patients with inflammatory lung diseases including persistent asthma. In infants and young children with persistent asthma, day- and night-time symptom scores, and the...

  • Inhaled Mometasone Furoate: A Review of its Use in Adults and Adolescents with Persistent Asthma. Sharpe, M.; Jarvis, B. // Drugs;Jul2001, Vol. 61 Issue 9, p1325 

    Mometasone furoate is a corticosteroid with relatively high in vitro potency. Recent randomised, double-blind, multicentre trials have assessed the efficacy of mometasone furoate delivered by dry powder inhaler over 12 weeks in adults and adolescents with mild to severe persistent asthma....

  • LUNG ALERT: Doubling the dose of inhaled corticosteroid for asthma exacerbations does not decrease subsequent use of systematic steroids. Soth, M. // Thorax;Apr2004, Vol. 59 Issue 4, p346 

    This double blinded trial with concealed randomisation compared doubling the dose of inhaled corticosteroid for 14 days with continuing the same dose when asthma symptoms or peak flow worsened in patients monitoring themselves daily at home. All patients were using an inhaled corticosteroid...

  • Choosing Therapy for Childhood Asthma. Holgate, Stephen T.; Frew, Anthony J. // New England Journal of Medicine;12/04/97, Vol. 337 Issue 23, p1690 

    Editorial. Focuses on choosing a therapy for childhood asthma. The availability of inhaled corticosteroids, cromolyn sodium or nedocromil sodium, beclomethasone dipropionate and salmeterol; Other options, such as environmental interventions; Reference to work by Simons et al in same issue.

  • Budesonide Inhalation Suspension for the Treatment of Asthma in Infants and Children. Berger, William E. // Drugs;2005, Vol. 65 Issue 14, p1973 

    On the basis of the well recognised role of inflammation in the pathogenesis of asthma, anti-inflammatory therapy, in the form of inhaled corticosteroids, has become the mainstay of treatment in patients with persistent asthma. Budesonide inhalation suspension (BIS) is a nonhalogenated...

  • Pranlukast: A Review of its Use in the Management of Asthma. Keam, Susan J.; Lyseng-Williamson, Katherine A.; Goa, Karen L. // Drugs;2003, Vol. 63 Issue 10, p991 

    Pranlukast (Onon[sup ®], Azlaire[sup ®]), is an orally administered, selective, competitive antagonist of the cysteinyl leukotrienes (LT) C[sub 4], LTD[sub 4] and LTE[sub 4]. It is indicated for the prophylactic treatment of chronic bronchial asthma in paediatric and adult patients. The...

  • Montelukast: A Review of its Therapeutic Potential in Persistent Asthma. Jarvis, B.; Markham, A. // Drugs;Apr2000, Vol. 59 Issue 4, p891 

    Montelukast is a cysteinyl leukotriene receptor antagonist used to treat persistent asthma in patients aged ≥6 years. The drug has a rapid onset of action. Improvements in lung function and reductions in as-needed β-agonist usage are apparent within 1 day of initiating montelukast...


Read the Article


Sign out of this library

Other Topics